Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/head-and-neck-cancer/descriptif_3849791
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3849791

Head and Neck Cancer, 1st ed. 2016 Multimodality Management

Langue : Anglais

Coordonnateur : Bernier Jacques

Couverture de l’ouvrage Head and Neck Cancer
?This second edition ?provides a comprehensive view of consolidated and innovative concepts, in terms of both diagnosis and treatment. Written by leading international physicians and investigators, this book emphasizes the necessity of combining local and systemic treatments to achieve the objective of yielding higher cure rates and lower toxicities. Heavily updated from the previous edition, it highlights new surgery and radiotherapy techniques, disease awareness, patient quality of life, and comprehensive management. 

Head-and-neck cancers are a complex clinical entity and their response to treatment is also known to vary markedly in function of host-related factors. Notwithstanding the impressive progresses observed in the field of imaging, head and neck cancers are often diagnosed at a late stage and the presence of locally advanced disease in a significant number of patients implies the use of aggressive treatments in order to both ensure local disease control and reduce distant metastasis risks. 

In comparison with the first edition, Head and Neck Cancer, Second Edition provides a detailed update of innovative concepts in chemo- and bio-radiation, viral infection impact on tumor growth and response to treatment, and impact of tumor- and host-related factors on treatment outcome. 

Table of Contents
Head and Neck Cancer: Multimodality Management, 2nd Edition

Editors: Jacques Bernier

Ch. 1: Epidemiology and Aetiology of Head and Neck Cancers
Newell W. Johnson
Hemantha K. Amarasinghe

Ch. 2: Head and Neck Cancer Prevention
Fausto Chiesa
Angelo Ostuni
Roberto Grigolato
Luca Calabrese
Mohssen Ansarin

Ch. 3: Cellular and Molecular Pathology of Head and Neck Tumors
Adel K. El-Naggar

Ch. 4: Oncogenomics/Proteomics of Head and Neck Cancers
Jason I. Kass
Howard S. Moskowitz
Jennifer R. Grandis

Ch. 5: Genetics and Epigenetics of Head and Neck Cancer
Jagtar Dhanda
Richard J. Shaw

Ch. 6: Immunology of Head and Neck Cancer
Benjamin A. Kansy
Steve C. Lee
Robert L. Ferris

Ch. 7: Biomarkers in Head and Neck Cancer
Hyunseok Kang
Christine H. Chung
Arlene A. Forastiere

Ch. 8: HPV and EBV in Head and Neck Cancer
Jeffrey Brumbaugh
Robert L. Ferris
Shen Hu

Ch. 9: Head and Neck Cancer Staging and Prognosis: Perspectives of the UICC and the AJCC
Brian O’Sullivan
Jatin P. Shah
William M. Lydiatt

Ch. 10: Preclinical Models of Head and Neck Squamous Cell Carcinoma
C.L. Zuur
A.J.C. Dohmen
Michiel W. van den Brekel
Xiao-Jing Wang
Stephen Malkoski

Ch. 11: Translational Research in Head and Neck Oncology
David S. Yoo
David M. Brizel

Ch. 12: Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment
Yungan Tao
Jean Bourhis

Ch. 13: Imaging of Head and Neck Cancers
Taha S. Meraj
Suyash Mohan
Gaurang V. Shah

Ch. 14: Ultrasound Investigations in Head & Neck Cancer Patients
Yolanda Y.P. Lee
Ka Tak Wong
Kunwar Suryaveer Singh Bhatia
Anil Tejbhan Ahuja

Ch. 15: Sentinel Node Biopsy
Oliver J. Smith
Lee W.T. Alkureishi
Gary L. Ross

Ch. 16: Intensity-Modulated Radiation Therapy for Head and Neck Cancer
Marsha Reyngold
Edward J. Shin
Nancy Lee

Ch. 17: Stereotactic Radiotherapy in Head and Neck Cancer Patients
Thomas Leroy
Eric Lartigau

Ch. 18: Proton Beam Therapy for Head and Neck Cancer
Danielle N. Margalit
Judy A. Adams
Hanne M. Kooy
Annie W. Chan
<
Ch. 19: Principles of Systemic Chemotherapy for Squamous Cell Head and Neck Cancer
Cristina P. Rodriguez
David J. Adelstein

Ch. 20: Molecular Targeted Therapies in Head and Neck Cancer
Zachary S. Morris
Anne M. Traynor
Paul M. Harari

Ch. 21: Laser Endoscopic Treatment
Pierre Moreau
Pierre Demez

Ch. 22: Transoral robotic surgery in head and neck cancer
Sylvain Morinière 

Ch. 23: Multidisciplinary Management of Skull Base and Superstructure Tumors
Giulio Cantù
Carlo L. Solero
Stefano Riccio
Sarah Colombo
Madia Pompilio

Ch. 24: Multidisciplinary management of oral cavity and maxillary sinus cancers
Alexander D. Rapidis

Ch. 25: Oral Oncology
Ruth Aponte Wesson
Theresa M. Hofstede
Richard C. Cardoso
Pattii Montgomery
Alexander M. Won
Jack W. Martin
Mark S. Chambers

Ch. 26: Management of Nasopharyngeal Carcinoma
Wai Tong Ng
Roger K.C. Ngan
Siu Hong Chan
Henry Sze
Jimmy Y.W. Chan
Anne W.M. Lee

Ch. 27: Multidisciplinary management of oropharynx carcinomas
Beth M. Beadle
David I. Rosenthal

Ch. 28: Multidisciplinary Management of Hypopharyngeal Carcinoma
Marc Hamoir
Jean-Pascal Machiels
Sandra Schmitz
Vincent Gregoire

Ch. 29: Cancers of the Larynx: Tis, T1, T2 Evaluation and Management
Carol M. Lewis
Steven B. Chinn
Chris Holsinger
Randal S. Weber

Ch. 30: Diagnosis and Multidisciplinary Treatment of Laryngeal Cancers
Nabil F. Saba
J. Trad Wadsworth
Jonathan J. Beitler
Fadlo R. Khuri

Ch. 31: Programs of Organ and Function Preservation
Jean Louis Lefebvre

Ch. 32: Principles and New Approaches in Surgical Reconstruction
Andreas Dietz
Milos Fischer
Christina Magill
Bruce H. Haughey

Ch. 33: Multidisciplinary treatment of the neck
Remco de Bree
Johannes A. Langendijk
C.R. Leemans

Ch. 34: Postoperative Management of High-Risk Resectable Head and Neck Cancer
Assuntina G. Sacco
Ezra E. Cohen

Ch. 35: Multidisciplinary Approach of Unresectable Head and Neck Cancer
Ricardo Hitt
Ana Lopez-Martin
Juan J. Cruz
Robert I. Haddad

Ch. 36: Management of Salivary Gland Cancer
Laura D. Locati
Marco Guzzo
Ester Orlandi
Lisa Licitra

Ch. 37: Primary Mucosal Melanomas of the Head and Neck
Juliette Thariat
Anne-Catherine Baglin
Pierre Yves Marcy
Caroline Even
Antoine Moya-Plana
Yusuke Demizu
Adam S. Garden
Marco Krengli
Michael A. Postow

Ch. 38: Head & Neck Cutaneous Melanoma
Mina N. Le
Michael A. Postow
Snehal G. Patel

Ch. 39: Cervical Lymph Node Metastases Of Squamous Cell Carcinoma From An Unknown Primary Site
Nicholas Pavlidis
Georgios Plataniotis

Ch. 40: The Management of Thyroid and Parathyroid Cancer
Nasheed M. Hossain
Colleen Veloski
Ranee Mehra

Ch. 41: Head and Neck Paragangliomas
Julian Künzel
Michael Hainz
Heidi Rossmann
Christoph Matthias

Ch. 42: Systemic Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Petr Szturz
Jan B. Vermorken

Ch. 43: Phase I study methodology in head and neck oncology
Aaron Hansen
Christophe Le Tourneau

Ch. 44: Treatment of the Elderly Head and Neck Cancer Patient
Jean-Claude Horiot
Matti Aapro

Ch. 45: Normal Tissue Complications and Protection in Head and Neck Cancer Patients
Andy Trotti
Nikhil Rao
Avraham Eisbruch
David I. Rosenthal

Ch. 46: Advances in Management of Complications for Head and Neck Cancer Therapy
Barbara Murphy
Jie Deng
Mark J. Stavas
Heidi Ganzer
Joel B. Epstein

Ch. 47: Rehabilitation of Heavily Treated Head and Neck Cancer Patients
Katherine A. Hutcheson

Ch. 48: Salvage Therapy in Head and Neck Cancer Patients
John Heaphy
Rod Rezaee
Pierre Lavertu

Ch. 49: Quality of Life in Head and Neck Cancer Patients
Jolie Ringash

Ch. 50: Psycho-oncologic aspects of head and neck cancer patients
Michel Reich

Ch. 51: Advances in Nanomedicine for Head and Neck Cancer
Sajanlal R. Panikkanvalappil
Mostafa A. El-Sayed
Ivan H. El-Sayed

Ch. 52: Head and Neck Quality Assurance 2014
Thomas J. FitzGerald
Maryann Bishop-Jodoin
David S. Followill
James M. Galvin
Michael V. Knopp
Jeff M. Michalski
Mark Rosen
Jonathan M. Glanzman
Paul Rava
Allison Sacher
David J. Goff
Alec Vaezi
Kenneth Ulin

After obtaining his degree in Radio-Oncology at the University of Liege, Belgium, Jacques Bernier completed his training at the MD Anderson Cancer Center, Houston, and the Curie Institute, Paris. In 2006 he joined the Swiss Genolier Medical Network, where since then he has been chairing the Radio-Oncology Department. Throughout most of his career, Jacques Bernier has been heavily involved with translational and clinical research. From 2000 to 2006 Jacques Bernier was Chairman of the Head and Neck Group of the EORTC. He currently serves as an Editorial Board member of various international peer-reviewed journals, including “Journal of Clinical Oncology”. He is an Associate Editor of “Annals of Oncology” (since 2010), and “Oral Oncology” (since January 2011). A Course Director at the European School of Oncology since 1990, Jacques Bernier is also the Chairman of the International Conference on Translational Research in Radio-Oncology - ICTR, organized every three years in Switzerland. He serves as a regular member of advisory boards for many pharmaceutical companies. He is President of the Foundation for the Advancement of Radiation Oncology – FARO, in Geneva, member of the Executive Board of Euro-Asian Society of Mastology - EURAMA, Board of Trustees of “Science for Peace” and Scientific Committee of the “Umberto Veronesi Foundation” in Milan.

Provides a comprehensive view of both consolidated and innovative concepts in diagnosis and treatment?

Emphasizes the necessity of combining local and systemic treatments

Covers topics such as epidemiology and etiology, diagnosis modalities, global management of individual cancers, quality assurance programs, patient rehabilitation, salvage treatments, health economics, and psycho-oncology

Discusses new surgery and radiotherapy techniques, disease awareness, patient quality of life, and comprehensive management

Provides a detailed update of innovative concepts in chemo-and bio-radiation, viral infection impact on tumor growth and response to treatment, and impact of tumor and host-related factors on treatment outcome

Date de parution :

Ouvrage de 878 p.

21x27.9 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 263,74 €

Ajouter au panier

Date de parution :

Ouvrage de 878 p.

21x27.9 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 263,74 €

Ajouter au panier